Bessalaar Moex (moexipril)
Executive Summary
Antihypertensive designated "approvable" May 20. The contract research organization holds the IND for Schwarz AG's drug. Bessalaar received approval Feb. 14 for Rhinocort (budesonide) for allergic rhinitis